Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Net Income (2018 - 2025)

Health Catalyst's Net Income history spans 8 years, with the latest figure at -$91.0 million for Q4 2025.

  • For Q4 2025, Net Income fell 340.31% year-over-year to -$91.0 million; the TTM value through Dec 2025 reached -$178.0 million, down 156.07%, while the annual FY2025 figure was -$178.0 million, 156.07% down from the prior year.
  • Net Income reached -$91.0 million in Q4 2025 per HCAT's latest filing, down from -$22.2 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$13.5 million in Q2 2024 to a low of -$91.0 million in Q4 2025.
  • Average Net Income over 5 years is -$32.8 million, with a median of -$31.5 million recorded in 2023.
  • Peak YoY movement for Net Income: surged 58.56% in 2024, then crashed 340.31% in 2025.
  • A 5-year view of Net Income shows it stood at -$48.9 million in 2021, then grew by 26.97% to -$35.7 million in 2022, then increased by 15.19% to -$30.3 million in 2023, then soared by 31.8% to -$20.7 million in 2024, then plummeted by 340.31% to -$91.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Net Income are -$91.0 million (Q4 2025), -$22.2 million (Q3 2025), and -$41.0 million (Q2 2025).